loading
Baxter International Inc stock is traded at $30.50, with a volume of 4.93M. It is down -0.65% in the last 24 hours and down -1.55% over the past month. Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
See More
Previous Close:
$30.70
Open:
$30.36
24h Volume:
4.93M
Relative Volume:
1.14
Market Cap:
$15.65B
Revenue:
$11.89B
Net Income/Loss:
$-560.00M
P/E Ratio:
-27.73
EPS:
-1.1
Net Cash Flow:
$191.00M
1W Performance:
+1.26%
1M Performance:
-1.55%
6M Performance:
-9.52%
1Y Performance:
-8.76%
1-Day Range:
Value
$29.93
$30.69
1-Week Range:
Value
$29.93
$31.04
52-Week Range:
Value
$26.25
$40.49

Baxter International Inc Stock (BAX) Company Profile

Name
Name
Baxter International Inc
Name
Phone
(224) 948-2000
Name
Address
ONE BAXTER PARKWAY, DEERFIELD, IL
Name
Employee
38,000
Name
Twitter
@baxter_intl
Name
Next Earnings Date
2024-11-08
Name
Latest SEC Filings
Name
BAX's Discussions on Twitter

Compare BAX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Instruments & Supplies icon
BAX
Baxter International Inc
30.50 15.46B 11.89B -560.00M 191.00M -1.10
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
552.34 193.38B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
172.59 49.12B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
85.94 42.79B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
244.79 35.61B 5.02B 1.31B 1.56B 8.91

Baxter International Inc Stock (BAX) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-26-25 Resumed Goldman Buy
Feb-24-25 Upgrade Argus Hold → Buy
Feb-20-25 Resumed Barclays Overweight
Jul-15-24 Downgrade Morgan Stanley Equal-Weight → Underweight
May-30-24 Initiated Goldman Neutral
May-10-24 Downgrade TD Cowen Buy → Hold
May-30-23 Resumed Morgan Stanley Equal-Weight
Mar-29-23 Initiated UBS Neutral
Jan-06-23 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-05-23 Downgrade Raymond James Outperform → Mkt Perform
Jan-03-23 Downgrade BofA Securities Buy → Neutral
Dec-19-22 Downgrade JP Morgan Overweight → Neutral
Dec-15-22 Downgrade Deutsche Bank Buy → Hold
Dec-12-22 Downgrade Citigroup Buy → Neutral
Oct-18-22 Initiated Barclays Overweight
Oct-12-22 Initiated Jefferies Hold
Jun-24-22 Downgrade Wells Fargo Overweight → Equal Weight
Apr-04-22 Downgrade Goldman Neutral → Sell
Mar-02-22 Resumed BofA Securities Buy
Feb-18-22 Reiterated KeyBanc Capital Markets Overweight
Feb-18-22 Reiterated Morgan Stanley Overweight
Feb-18-22 Reiterated Raymond James Outperform
Feb-18-22 Reiterated Stifel Buy
Feb-18-22 Reiterated UBS Neutral
Feb-18-22 Reiterated Wells Fargo Overweight
Feb-11-22 Initiated Goldman Neutral
Jan-07-22 Resumed Citigroup Buy
Jan-07-22 Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-13-21 Upgrade Cowen Market Perform → Outperform
Sep-03-21 Upgrade Barclays Equal Weight → Overweight
May-25-21 Initiated Barclays Equal Weight
Jan-29-21 Downgrade Piper Sandler Overweight → Neutral
Jan-06-21 Downgrade UBS Buy → Neutral
Dec-15-20 Downgrade Goldman Buy → Neutral
Oct-01-20 Upgrade Citigroup Neutral → Buy
Sep-04-20 Downgrade Argus Buy → Hold
Jun-24-20 Initiated Oppenheimer Outperform
Mar-19-20 Upgrade Stifel Hold → Buy
Mar-18-20 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Mar-05-20 Initiated Citigroup Neutral
Feb-13-20 Initiated Goldman Buy
Jan-02-20 Upgrade Evercore ISI In-line → Outperform
Dec-17-19 Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-26-19 Initiated KeyBanc Capital Markets Sector Weight
Apr-08-19 Downgrade Evercore ISI Outperform → In-line
Jan-02-19 Upgrade Citigroup Neutral → Buy
Jan-02-19 Upgrade Morgan Stanley Underweight → Overweight
Nov-02-18 Upgrade Argus Hold → Buy
Oct-16-18 Initiated Barclays Underweight
May-17-18 Resumed Piper Jaffray Overweight
Feb-06-18 Reiterated Citigroup Neutral
Jan-03-18 Initiated Evercore ISI Outperform
Jan-03-18 Upgrade Raymond James Mkt Perform → Outperform
View All

Baxter International Inc Stock (BAX) Latest News

pulisher
May 31, 2025

California State Teachers Retirement System Trims Stake in Baxter International Inc. (NYSE:BAX) - MarketBeat

May 31, 2025
pulisher
May 30, 2025

GF Fund Management CO. LTD. Buys Shares of 12,513 Baxter International Inc. (NYSE:BAX) - MarketBeat

May 30, 2025
pulisher
May 30, 2025

Canada Clinical Nutrition Market Is Booming WorldwideBaxter, B. Braun Melsungen - openPR.com

May 30, 2025
pulisher
May 30, 2025

Baxter International (BAX) Traded Higher Despite Tariff Disruptions - Insider Monkey

May 30, 2025
pulisher
May 30, 2025

Public Employees Retirement System of Ohio Makes New Investment in Baxter International Inc. (NYSE:BAX) - MarketBeat

May 30, 2025
pulisher
May 30, 2025

$3.94 Bn IV Hydration Therapy Markets - GlobeNewswire Inc.

May 30, 2025
pulisher
May 29, 2025

Vitiligo Market Forecast and Competitive Landscape Report 2025-2033 Featuring Incyte, Bristol-Myers Squibb, Clinuvel Pharmaceuticals, Astellas, Baxter, Pfizer, and Dr. Reddy's LaboratoriesResearchAndMarkets.com - FinancialContent

May 29, 2025
pulisher
May 29, 2025

IV Bag Market Is Booming WorldwideBaxter, B. Braun - openPR.com

May 29, 2025
pulisher
May 27, 2025

BAXTER TO Present at Goldman Sachs 46th Annual Global Healthcare Conference 2025 | BAX Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Exclusive: Baxter CFO to Share Strategic Updates at Goldman Sachs Healthcare Conference - Stock Titan

May 27, 2025
pulisher
May 27, 2025

Q3 EPS Forecast for Baxter International Cut by Analyst - MarketBeat

May 27, 2025
pulisher
May 25, 2025

Do These 3 Checks Before Buying Baxter International Inc. (NYSE:BAX) For Its Upcoming Dividend - simplywall.st

May 25, 2025
pulisher
May 25, 2025

We Wouldn't Be Too Quick To Buy Baxter International Inc. (NYSE:BAX) Before It Goes Ex-Dividend - Yahoo Finance

May 25, 2025
pulisher
May 23, 2025

Baxter International Inc. (NYSE:BAX) Given Consensus Rating of "Hold" by Analysts - MarketBeat

May 23, 2025
pulisher
May 22, 2025

Raiffeisen Bank International AG Purchases Shares of 76,587 Baxter International Inc. (NYSE:BAX) - MarketBeat

May 22, 2025
pulisher
May 20, 2025

Baxter launches room-temperature collagen sealing pad - MassDevice

May 20, 2025
pulisher
May 20, 2025

Baxter launches HEMOPATCH Sealing Hemostat, a room-temperature collagen pad approved for Hemostasis and Sealing, suitable for open surgery and minimally invasive surgical procedures (MIS) - PR Newswire

May 20, 2025
pulisher
May 19, 2025

Unpacking Q1 Earnings: Baxter (NYSE:BAX) In The Context Of Other Medical Devices & SuppliesDiversified Stocks - Yahoo Finance

May 19, 2025
pulisher
May 19, 2025

Parkwood LLC Invests $10.75 Million in Baxter International Inc. (NYSE:BAX) - MarketBeat

May 19, 2025
pulisher
May 18, 2025

Baxter International Inc. (NYSE:BAX) Receives Consensus Rating of “Hold” from Analysts - Defense World

May 18, 2025
pulisher
May 18, 2025

Baxter’s Q4 Performance Beats Expectations - Medical Product Outsourcing

May 18, 2025
pulisher
May 14, 2025

Baxter at Bank of America 2025 Healthcare Conference: Strategic Shifts and Growth - Investing.com Nigeria

May 14, 2025
pulisher
May 13, 2025

Becton Dickinson Sues Baxter Over Infusion Pump Patents - Law360

May 13, 2025
pulisher
May 13, 2025

BD files patent infringement lawsuit against Baxter over infusion pump tech - Drug Delivery Business

May 13, 2025
pulisher
May 13, 2025

Becton Dickinson Says Baxter Infringes Infusion-Pump Patents - Bloomberg Law News

May 13, 2025
pulisher
May 13, 2025

Transcript : Baxter International Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Hurricane Helene Updates - Baxter

May 13, 2025
pulisher
May 12, 2025

Ameriprise Financial Inc. Sells 2,346,164 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat

May 12, 2025
pulisher
May 10, 2025

Morgan Stanley Has Lowered Expectations for Baxter International (NYSE:BAX) Stock Price - MarketBeat

May 10, 2025
pulisher
May 08, 2025

Baxter International Inc. (BAX) Announces Results of 2025 Annual Meeting - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Baxter International Holds 2025 Annual Meeting with Key Decisions - TipRanks

May 08, 2025
pulisher
May 08, 2025

Baxter International Inc (BAX) Shares Up 4.23% on May 8 - GuruFocus

May 08, 2025
pulisher
May 08, 2025

The 'Goldilocks' Case For Baxter International (NYSE:BAX) - Seeking Alpha

May 08, 2025
pulisher
May 08, 2025

SHAREHOLDER ALERT: Potential Recovery for Baxter International Inc. (BAX) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

May 08, 2025
pulisher
May 07, 2025

Baxter International First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Beyond the Balance Sheet: What SWOT Reveals About Baxter Interna - GuruFocus

May 07, 2025
pulisher
May 06, 2025

Baxter International IncDeclares Quarterly Dividend Of $0.17 Per Share - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

Baxter Declares Quarterly Dividend | BAX Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Baxter Declares Quarterly Dividend - Bluefield Daily Telegraph

May 06, 2025
pulisher
May 06, 2025

Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL.com

May 06, 2025
pulisher
May 06, 2025

What Are Wall Street Analysts' Target Price For Baxter International Stock? - Barchart.com

May 06, 2025
pulisher
May 06, 2025

What Are Wall Street Analysts' Target Price for Baxter International Stock? - inkl

May 06, 2025
pulisher
May 06, 2025

Analysts Offer Insights on Healthcare Companies: Baxter International (BAX) and Vera Therapeutics (VERA) - The Globe and Mail

May 06, 2025
pulisher
May 04, 2025

Wells Fargo & Company Issues Pessimistic Forecast for Baxter International (NYSE:BAX) Stock Price - Defense World

May 04, 2025

Baxter International Inc Stock (BAX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_instruments_supplies WST
$210.85
price up icon 0.19%
$62.17
price down icon 1.19%
medical_instruments_supplies COO
$68.28
price down icon 14.61%
$180.94
price down icon 1.15%
$73.09
price up icon 0.66%
Cap:     |  Volume (24h):